中文摘要：

目的：考察20（S）-原人参二醇（20（S）-PPD）复合微球的体外长期和加速释药规律。方法：采用溶剂乳化挥发法制备药物复合微球,采用残余法测定药物在复合微球中的体外长期和加速释放度,评价两种体外释放之间的相关性,对体外长期释放模型进行拟合,研究微球体外长期释药机制。结果：复合微球的体外长期释放数据显示,药物无明显突释,释放至33d时,累积释放率达50.87%,具有明显缓释效果;体外长期释放曲线符合Higuchi方程,表明其体外长期释放以扩散机制为主;复合微球在37℃体外长期释放的累积释放率（Q37,%）与50℃下加速释放的累积释放率（Q50,%）的相关性拟合方程为ln（100-Q50）=2.1378ln（100-Q37）-5.1832,（r=0.9744）,体外长期和加速释放的相关性良好。结论：20（S）-PPD复合微球的体外长期释放表明,微球具有良好的缓释效果,可用体外加速释放评价法来指导微球的后续处方与工艺优化,为研发20（S）-PPD微球制剂提供了参考依据。

英文摘要：

Objective：To study the drug release in both long-term and accelerated situation of 20（S）-Pro-topanaxadiol complex microspheres.Methods：Prepared the microspheres by the emulsion solvent evaporation method.Residual method was used to determine the degree of the drug release of 20（S）-PPD both in long-term and accelerated situation.Evaluated the correlation between the two kinds of in vitro drug release,fit the model of long-term drug release,and studied the mechanism for the long-term drug release in vitro. Results：The long-term drug release data showed that there was no obvious burst release,when release for 33d the cumulative release rate was 50.87%,which showed that the microsphere had slow-release effect.In vitro long-term release curve conformed to Higuchi equation,it showed that the long-term in vitro release had given priority to diffusion mechanism.The correlation of fitting equation of the accumulation of long-term release in vitro release rate in both 37℃and 50℃was ln （100-Q 50 ）= 2.1378 ln （100-Q3 7 ）-5.1832,（r =0.9744）,the correlation between the in vitro long-term release and accelerated release was good.Conclusion：The long-term in vitro release of 20（S）-PPD microspheres shows that the microsphere has good slow release effect.We can use in vitro accelerated release evaluation method to guide the subsequent prescription and process optimization of microspheres,which provides a reference basis for developing the 20（S）-PPD micro-spheres.